DOCSLIB.ORG

Prescription and Over the Counter Medications Tool Kit April 2011

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Prescription and Over the Counter Medications Tool Kit April 2011 U.S. Department Prescription and Over-the-Counter Of Transportation Federal Transit Medications Tool Kit Administration Office of Safety and Security April 2011 Table of Contents TABLE OF CONTENTS Section Page Disclaimer 1 Introduction 2 How to Use this Toolkit 5 I. Rx/OTC Medication Overview and List of Commonly Used Rx/OTC Medications I‐1 II. Rx/OTC Medication Policies and Procedures II‐1 III. Accident Investigation Procedures III‐1 IV. Forms IV‐1 V. Training V‐1 VI. Resources VI‐1 Appendices Summary Table of Best Practices 1 Frequently Asked Questions 2 OTC Medications with Alcohol 6 Table of Contents FTA Prescription/Over­the­Counter Medication Toolkit Page i Disclaimer DISCLAIMER The policies, procedures, and other information contained in this Prescription and Over‐ the‐Counter (Rx/OTC Medications) Toolkit does not constitute Federal Regulation. The content is a presentation of the best practices and model forms and policies being used at various transit systems throughout the U.S. at the writing of this Toolkit. Neither does the information presented reflect the only practices to be followed for the monitoring of Rx/OTC medication use, but rather it should be used as a baseline for a program to be molded to fit the individual needs of each transit system. Sound medical knowledge and understanding of the pharmacological properties of prescription and over‐the‐counter medications, together with detailed knowledge of an employee’s medical history and safety‐sensitive job duties, must guide each transit system’s final assessment of potential risks to the public. This document is draft and confidential. Information contained within is intended only for use by the authors, RLS & Associates, Inc. and the Federal Transit Administration (FTA). If you are not the intended recipient, you are hereby notified that any disclosure, copying, or distribution is strictly prohibited without permission. Thank you. Disclaimer FTA Prescription/Over­the­Counter Medication Toolkit Page 1 Introduction INTRODUCTION In 2000, the National Transportation Safety Alcohol Testing, a regulation, nor a list of Board (NTSB) issued a directive to the approved/not approved medications. As a Federal Transit Administration (FTA) to direct result of the Toolkit, many within the educate transit agencies on the potential transit industry initiated and/or enhanced safety risks associated with the use of their Rx/OTC program by establishing prescription (Rx) and over‐the‐counter (OTC) policies, creating training programs, and medications by employees who perform implementing reporting mechanisms, many safety‐sensitive duties. using the samples contained in the Toolkit. The NTSB directive recommended that all The NTSB applauded FTA for its progress and transit rail agencies require employees in leadership in addressing the safety risks safety‐sensitive positions to inform their posed by the use of Rx/OTC medications in agency about their use of Rx/OTC the transit industry. The NTSB also medications. Knowledge of the employee’s subsequently recommended that the FTA use of medication would provide the transit establish a comprehensive toxicological rail agency with the opportunity to have testing requirement for a sample of fatal qualified medical personnel determine the transit accidents to identify the role played by potential effects of the medicines on common Rx/OTC medications. To meet the employee performance, and to train the NTSB expectation, the FTA would be required employees about their responsibility under to develop a standardized methodology to the agency’s Rx/OTC policy. collect the information on the role that Rx/OTC medications play in transit industry Shortly thereafter, in response to the NTSB fatal accidents and establish a meaningful directive, the FTA issued a challenge to all way to analyze and report the findings. FTA grant recipients to: ♦ Review policies related to employee use of Rx/OTC medications that could potentially compromise public safety; and ♦ Educate transit operators and their safety‐sensitive employees about the risks and potential dangers associated with the use of Rx and OTC medications. Subsequently in 2002, the Federal Transit As a first step in this effort, FTA undertook a Administration (FTA) published the comprehensive assessment of the current Prescription and Over­the­Counter Medication status of Rx/OTC policies within the transit (Rx/OTC) Toolkit as a tool to help educate industry to determine the extent to which transit systems about the potential safety transit systems were collecting and risks associated with Rx/OTC medication use maintaining data regarding the role Rx/OTC by transit system employees. The toolkit medications play in fatal accidents. This contained a collection of policies, procedures, assessment included an extensive data training aids, and post‐accident procedures. gathering and analysis process and the Its purpose was safety and technical national evaluation of policies, procedures, assistance. Its purpose was not Drug and Introduction FTA Prescription/Over­the­Counter Medication Toolkit Page 2 and post‐accident investigations utilized by One‐on‐one interviews were conducted as FTA recipients. part of Step 3. It was through this process that information was gained to guide the A three‐step data collection approach was latter stages of the project. Finally, Step Four, used: a followup of randomly selected accidents as reported through the NTD, was conducted. It 1. Conducting a data search which included was here that much of the data that guided the National Transit Database and any the recommendations of the study was data or research conducted by other gathered. federal agencies, such as the Federal Motor Carrier Safety Administration, In the nearly nine years since the original Federal Aviation Administration, Federal effort, many transit systems have refined and Railroad Administration, etc.; enhanced their Rx/OTC policies and 2. Surveying public transit systems programs as evidenced by the surveys. receiving FTA funding; and Nearly two‐thirds of the participating 3. Conducting one‐on‐one interviews with systems indicated that they do address selected transit systems. Rx/OTC medications as part of their organization’s Substance Abuse Policy. This Into the project, based on the information is a significant finding, on one hand, because that was collected, or not collected, as part of in 2002 transit systems were in the infancy the survey process, it was decided to add a stages of addressing Rx/OTC medications as fourth step to the study: part of their overall Drug and Alcohol Testing Program. However, there are still several 4. Conduct a follow‐up of randomly selected concerns. First, a full one‐third of survey transit accidents as reported via the respondents still do not address Rx/OTC National Transit Database (NTD). medication use as part of their substance abuse awareness program. Second, and Four years of NTD data were studied as part perhaps of even greater concern, further of Step 1, as well as data from the Federal research with the transit systems that do Motor Carrier Safety Administration (FMCSA) address Rx/OTC medication use revealed that via their National Truck Causation Study. the majority actually do nothing with the Step Two included two online questionnaires information they collect. Thus, there is still which provided much of the information much to do to address Rx/OTC medication contained in this toolkit. The first use as it impacts transit system safety. questionnaire solicited information regarding a transit system’s accident investigation This toolkit includes a variety of best procedures, data collection methodologies, practices from those systems and a model and methods used to determine the role Rx/OTC Medication Program that one State Rx/OTC medications play in accidents. The has implemented for its FTA Section 5311 second questionnaire solicited information transit operators. For the transit systems regarding each transit system’s Rx/OTC that have yet to address the use of Rx/OTC policy. medications by safety‐sensitive employees, this Toolkit will serve as a baseline for The information obtained from the 300 plus implementing such a program. It will also be systems that completed the surveys as part of a useful toolk for those transit systems that Step 2 formed the basis for this update of the are currently reviewing their existing Prescription and Over‐the‐Counter (Rx/OTC) programs and can serve to enhance or expand Medication Toolkit. those programs. Introduction FTA Prescription/Over­the­Counter Medication Toolkit Page 3 To read the Final Report of the Prescription and Over‐the‐Counter (Rx/OTC) Medication Study, or obtain additional copies of this Toolkit, contact the FTA Drug and Alcohol Hotline at (617)494‐6336 or via e‐mail to [email protected]. Introduction FTA Prescription/Over­the­Counter Medication Toolkit Page 4 How to Use This Toolkit HOW TO USE THIS TOOLKIT What is the Rx/OTC Toolkit? For example, if a transit system is only beginning to develop its Rx/OTC policy, or is This Toolkit is a compilation of policies, looking to revise its existing policy, the Policies procedures, forms, and training resources that and Procedures Section provides several represent the best practices being used examples of excellent working policies as well throughout the U.S. by a variety of transit as a model policy for “fill in the blank” that is systems. It does not represent all of the currently being used in one state for all of its effective means that transit systems are using FTA Section 5311 transit operators. Use partial to address and monitor Prescription (Rx) and or entire sections of the samples or use them in Over‐the‐Counter (OTC) medication use, but is their entirety as it fits each transit system’s the result of an extensive effort by the Federal needs. The same is true of all Toolkit sections. Transit Administration (FTA) to compile a Whether a transit system is re‐starting from broad range of materials as examples and scratch or simply trying to evaluate or update models.
Load more

Recommended publications
  • Information About Cough Medicine (DXM)
    Myth: Abusing Over-The-Counter Drugs Are Safe Vancouver Island Information Teens may mistakenly believe that cough Youth & Family medicines sold in stores are less dangerous than about Cough street drugs. Even parents may underestimate Addiction Services the seriousness of DXM abuse and feel relief Medicine (DXM) that their children are "only abusing cough syrup, not illegal drugs." Although cough What is Dextromethorphan (DXM)? medicine is sold in stores and is a regulated product, the reality is that taking large quantities of DXM has the potential to be extremely Dextromethorphan (DXM) is a cough dangerous and even fatal. When taken in suppressant ingredient contained in over-the-counter medicines. combination with other medicines or illicit drugs DXM is found the risk increases significantly. in more than 100 over-the-counter If A Teen Is Using cough and cold medications in syrup, tablet, lozenge Sit down with the youth and openly voice your and capsule form. Taken in suspicions but avoid direct accusations. Do not suggested doses, DXM is have this conversation when the youth is under generally a safe and the influence of a substance. Stay calm and effective rational. cough medication. Seek medical attention immediately if the youth is unresponsive to your voice, vomiting, very Dextromethorphan is found in over-the-counter pale or has a bluish tinge to the skin. cough medicines, including Alka-Seltzer Plus Cold and Cough, Dimetapp DM, For More Information Sudafed cough medicine, Robitussin, Tylenol Cough and Cold medicine, Vicks 44 Cough To find out about services in your community, Relief medicine and many more.
    [Show full text]
  • Traveler's Diarrhea
    THE PRE-TRAVEL CONSULTATION Dr. Becky Reece, MD Lead physician at Lifespan Center of Excellence for Tick-borne Diseases Newport Hospital May 6, 2017 Some Slides from Dr. Kojic, Director of The Miriam Hospital Travel clinic Overview Epidemiology General recommendations The traveller Diseases Diarrhea Vector and animal bite prevention Immunizations Other travel related recommendations Travelers’ Health Risks Of 100,000 travelers to a developing country for 1 month: 50,000 will develop some health problem 8,000 will see a physician 5,000 will be confined to bed 1,100 will be incapacitated in their work 300 will be admitted to hospital 50 will be air evacuated 1 will die Among more than 42,000 ill returned travelers seen between 2007 and 2011 in the GeoSentinel surveillance network, the most common syndromic diagnoses were: gastrointestinal (34%) febrile illnesses (23%) dermatologic illnesses (19%) Asia (32%) and sub-Saharan Africa (25%) were the most common regions where illnesses were acquired. Approximately 40 percent of ill travelers reported pretravel medical visits. Travelers visiting friends and relatives in their country of origin had a disproportionately high burden of serious febrile illness and very low rate of advice prior to travel. Steffen R et al. J Infect Dis 1987. 156:84-91 GeoSentinel Surveillance of Illness in Returned Travelers, 2007–2011Leder K, Torresi J, Libman MD, et al Ann Intern Med. 2013;6(158):456. Causes of death Cardiovascular deaths 49% Cardiovascular Injuries, accidents 22% Medical Injury top on list Egypt, Kenya, Homicide/Suicide India Infectious Disease Other Medical illnesses 13.7% Infectious causes 1% Other Hargarten S et al, Ann Emerg Med, 1991.
    [Show full text]
  • Medication Other Information Aches and Pains Constipation Cough/Cold Diarrhea Fever Over the Counter Medications in Pregnancy
    Over the Counter Medications in Pregnancy Women commonly use over the counter medications in pregnancy. This is a list of those medication you may safely use during pregnancy. If you have any questions about these medications and how to use them please contact your Healthcare Provider's office. Unless otherwise stated please take the medication as directed on the manufactures label. Medication Other Information Aches and Pains * Tylenol Extra Strength 500 mg tablet No more than 6 tablets in a 24 hour period * Tylenol 325 mg tablet No more than 8 in a 24 hour period Constipation Stool Softener Increases the amount of water in your stools to make them easier to pass * Colace (docusate sodium) * Surfak (docusate calcium) * Docusate Fiber Laxative Increases the amount of bulk in your stools to make them easier to pass * Metamucil (psyllium) * Fibercon (Calcium polycarbophil 625 mg) Stool Softener/Fiber Laxative Increases the amount of water in your stools to make them easier to pass * Peri-Colace (docusate sodium/sennosides) * Senekot -S (docusate sodium/sennosides) Osmotic Laxative Increases the amount of water in your stools to make them easier to pass * Milk of Magnesia * MiraLax (polyethylene glycol 3350) Cough/Cold Expectorants Help thin mucus and phlegm so they can be coughed up * Robitussin * Guaifenesin Antihistamines Can be used to relieve seasonal allergy and common cold symptoms of nasal congestion, * Chlorpheniramine sneezing and itchy eyes Cough Suppressants Help calm a cough * Dextromethorphan Decongestants Are used to relieve
    [Show full text]
  • Notice Under S66 of the Commerce Act 1986 Application by Johnson & Johnson to Acquire the Stock, Assets and Business Of
    PUBLIC COPY Notice under s66 of the Commerce Act 1986 Application by Johnson & Johnson to acquire the stock, assets and business of the Consumer Healthcare division of Pfizer Inc. COMMERCE ACT 1986: BUSINESS ACQUISITION SECTION 66: NOTICE SEEKING CLEARANCE 28 September 2006 The Registrar Business Acquisitions and Authorisations Commerce Commission PO Box 2351 Wellington Pursuant to s66(1) of the Commerce Act 1986 notice is hereby given seeking clearance of a proposed business acquisition. 518689_1.DOC 2 CONTENTS EXECUTIVE SUMMARY PART 1: TRANSACTION DETAILS 1 The business acquisition for which clearance is sought 2 The person giving this notice 3 Confidentiality 4 Participants 5 Interconnected and associated persons 6 Beneficial interests 7 Links between participants 8 Common directorships 9 Business activities of the participants 10 Reasons for the proposed acquisition PART II: IDENTIFICATION OF MARKETS AFFECTED 11 Horizontal aggregation 12 Differentiated product markets 13 Differentiated product markets 14 Vertical integration 15 Other business acquisitions PARTS III, IV AND V: CONSTRAINTS ON MARKET POWERS BY EXISTING AND POTENTIAL COMPETITION AND OTHER POTENTIAL CONSTRAINTS 16 Allergy medication 17 Products for the treatment of worms 18 Thrush treatment CERTIFICATE APPENDICES 1. Heartburn and indigestion remedies (MYLANTA and MOTILIUM) 2. Worm treatments (COMBANTRIN, VERMOX) 3. Cold, flu, nasal decongestant, cough relief and sort throat medications (CODRAL, SINUTAB, SUDAFED, BENADRYL, BRONDECON) 4. Allergy relief products (ACTIFED, SINUTAB, SUDAFED, VISINE, LIVOSTIN) 518689_1.DOC 3 5. Thrush treatments (DIFLUCAN ONE, DAKTARIN, DAKTAGOLD, NIZORAL, SPORANOX) 6. Shampoo (PREGAINE, ROGAINE, NEUTROGENA, JOHNSON’S BABY SHAMPOO) 7. Hand hygiene (PURELL and MICRO SHIELD) 8. Competitor worm treatment products 9. Multinational pharmaceutical businesses: GlaxoSmithKline, Douglas Pharmaceuticals, Alphapharm, Bayer Group 10.
    [Show full text]
  • BUFFERIN Light Search
    Read this sheet in full before using, and keep for later reference. Find more product info online Search BUFFERIN Light Light formula designed to be easy on the body* <Pain reliever/fever reducer> BUFFERIN Light Designated Class 2 OTC drugs Some BUFFERIN brand products contain different active ingredients. The pain relieving/fever reducing ingredient in this product is acetylsalicylic acid. When consulting a doctor, dentist, pharmacist or registered seller about this product, specify that the product you are asking about contains acetylsalicylic acid. BUFFERIN Light Formula Mild effectiveness* Contains no drowsiness-inducing ingredients Easy on the stomach Caffeine-free * The BUFFERIN Light formula contains a lower dose of analgesic ingredients than BUFFERIN A and contains ingredients that help protect the stomach Warnings Do not (Failure to comply with these instructions increases the likelihood of current symptoms worsening, side effects occurring, and other potentially serious risks) 1. Do not use this product if you (1) Have ever had an allergic reaction to this product or any of its ingredients (2) Have ever had an asthma attack after using this product, any other pain reliever/fever reducer, or a cold medicine (3) Are under 15 years old (4) Are pregnant and expecting to give birth within 12 weeks 2. Do not take any of the following pharmaceuticals while using this product Other pain relievers/fever reducers, cold medicines, sedatives 3. Do not consume alcohol before or after taking this product 4. Do not use this product continuously for extended periods Seek advice 1. Ask a doctor, dentist, pharmacist or registered seller before use if you are (1) Currently receiving treatment from a doctor or dentist (2) Pregnant or suspect you may be pregnant (3) Breast-feeding (4) Elderly 1 (5) Have ever shown allergic symptoms when taking a drug or medicine (6) Have been diagnosed with any of the following conditions: Heart disease; kidney disease; liver disease; stomach or duodenal ulcer 2.
    [Show full text]
  • Drug Alliance Information Alert Stackers, DMX: Coricidin & Robitussin Abuse and Ephedrine
    Drug Alliance Information Alert Stackers, DMX: Coricidin & Robitussin Abuse and Ephedrine • STACKERS are legal; over the counter dietary supplements used to assist in weight loss and muscle enhancement. These supplements can be extremely dangerous to your teenager's health . They are available at local drug and vitamin stores and gas stations. Ephedrine, the main ingredient, is a natural herb and therefore not currently regulated by the FDA. The FDA is now considering regulation, as a result of many young, health -conscious people suffering from strokes, heart conditions, and other serious illnesses related to stacker use. It has also been linked to anxiety, sleeplessness, migraines, high blood pressure, and seizures and in some instances ephedra has been link ed with death. • DMX: CORICIDIN & ROBITUSSIN ABUSE - Teens are abusing over - the -counter cold pills to get high The latest craze among teens is using over -the -counter cold medicines and cough syrup in excessive doses as recreational drugs b+ deliberately ing esting large amounts of Coricidin HBP -Cough & Cold Pills or Robitussin b+ as many as 15 tablets at once. The ingredient is DXM or dextromethorphan: a legal cough medicine ingredient which is uncontrolled by the government and is available in over 125 diffe rent products. These medicines can be purchased off the drugstore or supermarket counter. When used correctly, DXM suppresses coughs safely, but in large amounts it produces a chemical imbalance in the brain that allows the kids to get high. The DEA says abusers report an LSD -like high: a heightened sense of perceptual awareness, altered time perception and visual hallucinations.
    [Show full text]
  • Important Pharmacy Information There Is No Copay When Your Primary Care Provider (PCP) Or Unitedhealthcare Community Plan Specialist Writes You a Covered Prescription
    Important Pharmacy Information There is no copay when your Primary Care Provider (PCP) or UnitedHealthcare Community Plan Specialist writes you a covered prescription. But you can get many over-the-counter (OTC) medicines free when you have a prescription. You can get the medications listed on the following pages when they are medically necessary and you get a written prescription from your UnitedHealthcare Community Plan doctor and take it to a UnitedHealthcare Community Plan pharmacy. To get your medicine: • Take your prescription to a UnitedHealthcare Community Plan pharmacy. To find a pharmacy, call 1-800-903-5253 or go to UHCCommunityPlan.com. • For your safety, we urge you to select a single pharmacy from which to get your drugs. • Get to know the pharmacist and build a relationship. If the UnitedHealthcare Community Plan pharmacy says they cannot fill your covered prescription or you have to pay more than your copay: Do not leave the pharmacy. Do not pay for it yourself. Ask the pharmacy why they cannot fill your prescription. Response Your Solution Not Covered • Ask them to call OptumRx right away to find out which medicine is covered. • Ask them to call your doctor to see if you can get the covered medicine instead. Prior • Ask them to call your doctor for a prior authorization. Authorization • You can call your doctor and ask that a prior authorization be sent to: Needed UnitedHealthcare Pharmacy Prior Notification Service Fax 1-866-940-7328 Phone 1-800-310-6826 Refill Too Soon • Ask what day it can be filled. • Pick your prescription up the day it can be filled.
    [Show full text]
  • 2020 Over the Counter (OTC) Benefit Quick Reference Guide
    2020 Community Health Choice (HMO D-SNP) OVER-THE-COUNTER (OTC) BENEFIT QUICK REFERENCE GUIDE Texas: Austin, Brazoria, Chambers, Fort Bend, Galveston, Hardin, Harris, Jasper, Jefferson, Liberty, Matagorda, Montgomery, Newton, Orange, Polk, San Jacinto, Tyler, Walker, Waller, and Wharton CommunityHealthChoice.org/Medicare 833.276.8306 or 713.295.5007 (TTY 711) October 1 through March 31, 8:00 am to 8:00 pm, 7 days a week and April 1 through September 30, Monday through Friday, 8:00 am to 8:00 pm H9826_PH_10163_111919_C 2020 Community Health Choice (HMO D-SNP) OVER-THE-COUNTER (OTC) BENEFIT QUICK REFERENCE GUIDE Plan Service Area CommunityHealthChoice.org/Medicare 833.276.8306 or 713.295.5007 (TTY 711) October 1 through March 31, 8:00 am to 8:00 pm, 7 days a week and April 1 through September 30, Monday through Friday, 8:00 am to 8:00 pm H9826_PH_10163_111919_C Thank you for choosing to get your Medicare health care and your prescription drug coverage through our plan, Community Health Choice (HMO D-SNP). As a Community Health Choice member, How do I use the OTC benefit? Over-The-Counter (OTC) Benefits Over-The-Counter (OTC) you get a quarterly Over-the-Counter As a member of Community Health Choice, (OTC) benefit that allows you to purchase you may obtain qualified OTC products items such as cold and cough medicines, through any pharmacy. After you have vitamins, dental care items, pain relievers, purchased your OTC products, you will and much more. The information below need to submit copies of your itemized describes how to take advantage of this purchase receipts within 30 days after the benefit.
    [Show full text]
  • Cold Medicine Abuse
    Regional Center for Poison Control and Prevention Serving Massachusetts and Rhode Island Cold Medicine Abuse By Jill Griffin, MA/RI Regional Center for Poison Control and Prevention During the fall and winter months, it is not uncommon to see people carrying around bottles of cough medicine or taking cold pills on their break. It's the time of year for cold and flu, and many people choose to self- medicate to alleviate their symptoms. This includes adolescents, who can easily purchase these products at local stores. However, an increasing trend among young people is the abuse of over-the-counter (OTC) cold medications. Of particular concern is dextromethorphan or DXM, which is used in a variety of over-the-counter cough and cold medications, particularly those whose name includes “DM” or “Tuss”. DXM is a narcotic related to opium and is a cough suppressant that suppresses an area in your brain that causes you to cough. When used according to directions, the drug will alleviate cough, and is particularly helpful with night-time coughing that keeps you awake. However, when abused in higher doses, it creates a euphoric and hallucinogenic effect, similar to ecstasy and LSD. It alters perception of reality. People report having creative dreamlike experiences and a dissociative experience while using the drug. Increased media coverage of “Pharming” or intentional misuse of over-the- counter medicines, reveal that this practice is becoming more popular and potentially more deadly. It is cheap, legal, and readily available, and most parents won’t question their children for having cold medicine in their bags or rooms.
    [Show full text]
  • Daiichi Sankyo Group Value Report 2018
    External Evaluations (as of June 30,2018) ™ MSCI Japan Empowering Women Select Index THE INCLUSION OF DAIICHI SANKYO CO.,LTD. IN ANY MSCI INDEX, AND THE USE OF MSCI LOGOS, TRADEMARKS, SERVICE MARKS OR INDEX NAMES HEREIN, DO NOT CON- STITUTE A SPONSORSHIP, ENDORSEMENT OR PROMOTION OF DAIICHI SANKYO CO.,LTD. BY MSCI OR ANY OF ITS AF- FILIATES. THE MSCI INDEXES ARE THE EXCLUSIVE PROP- ERTY OF MSCI. MSCI AND THE MSCI INDEX NAMES AND LOGOS ARE TRADEMARKS OR SERVICE MARKS OF MSCI OR ITS AFFILIATES. Daiichi Sankyo Group Value Report 2018 Value Daiichi Sankyo Group Logo given to Certified Health and Productivity Management “Eruboshi” Certification Mark “Kurumin” Certification Mark Organization (White500) Value Report 2018 was printed using environmental-friendly paper, inks, and manufacturing method. This report uses FSC® certified 3-5-1, Nihonbashi-honcho, Chuo-ku, paper, which indicates that the paper used to print this report Tokyo 103-8426, Japan Paper was produced from properly Daiichi Sankyo Group Corporate Communications Department managed forests. Tel: +81-3-6225-1126 Value Report 2018 CSR Department This report was printed using Tel: +81-3-6225-1067 Inks 100% biodegradable printing inks from vegetable oil. https://www.daiichisankyo.com/ The waterless printing method Printing used for this report minimized the use and release of harmful liquid wastes. Printed in Japan 005_7045687913009.indd 1 2018/09/13 13:34:05 Cautionary Note Regarding Forward-Looking Editorial Policy Company’s website https://www.daiichisankyo.com/ Statements Management strategies and plans, financial Daiichi Sankyo began publishing Value Reports, its brand of integrated reports, in fiscal 2013.
    [Show full text]
  • IBUPROFEN Vs. ACETAMINOPHEN Acetaminophen, Toxicity Can Occur Even with the Recommended Dosages
    IBUPROFEN vs.IBUPROFEN ACETAMINOPHEN vs. ACETAMINOPHEN Which Painkiller is Better for Children with Viral Hepatitis? Adults and children with chronic viral hepatitis suffer the same fevers, colds and body aches as everyone. But parents of infected children and teens must carefully examine the array of over-the-counter painkillers available. Many of these medicines, if taken in excess or in combination with alcohol, can damage their children’s vulnerable livers. The danger does not come from occasional use of an over-the-counter painkiller, like Tylenol (acetaminophen). In fact, doctors often prescribe acetaminophen to ease side effects of interferon, used to treat children with chronic hepatitis. The danger comes from mixing a regular dose of acetaminophen with alcohol, or unwittingly taking an over-the-counter cold medicine, which already has acetaminophen in it, with a second direct dose of acetaminophen. Parents must exercise extra caution. Adults can confuse infant acetaminophen suspen- sion drops, which have far more concentrated levels of the drug, with children's less-concentrated medicine. Poisoning can occur if parents administer a teaspoon of infant Tylenol instead of a dropper-full. There are three main types of pain relievers available over-the-counter. Each has a different impact on the liver: • Acetaminophen (Tylenol, Anacin 3, Panadol and others) is a common pain killer for mild to moderate pain and is also effective in reducing high body temperature. This painkiller can cause liver failure if taken in overdose. When taken even in normal dosages with alcohol, it can cause liver damage. Patients with liver disease should use this drug with caution because their liver may not be able to metabolize the drug.
    [Show full text]
  • Cough/Cold, Allergy & Analgesics
    Industry Trends Report Cough/Cold, Allergy & Analgesics ANALGESIC TRENDS Private label analgesics make up nearly 40% of the total market. (See below chart) As Johnson & Johnson and Novartis push to get their largest analgesics brands back to pre-recall levels through a series of awareness campaigns, many consumers shift their purchasing preferences back to branded products. This helped the category to continue to thrive in 2014, achieving the second-strongest single-year growth in retail value sales of the past decade, trailing only 2013 when several brands were reintroduced to the market.* *Euromonitor International Percentage of the total analgesic-internal tablet sales in the United States in 2014, by leading brands. The statistic shows the percentage of total analgesic-internal tablet sales in the United States in 2014, by leading brands in that period, the Tylenol brand had 7.6 percent of total dollar sales in the United States. BC 1.3% Motrin IB 1.7% Exedrin 1.9% Exedrin Migraine 2.2% Advil PM 2.7% Bayer 7.1% Tylenol 7.6% Aleve 11.9% Advil 15.4% Private Label 39.1% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0% Statista 2015 ANALGESIC OPPORTUNITY PACKAGING, BRANDING & MESSAGING An aging baby boomer population and subsequent rise in geriatric Store brand and national brands (such a Nyquil) population, and rising therapeutic benefits of pain treatment drugs offer combination packs targeting both daytime (internal) are major factors driving growth in the global analgesics and nighttime symptoms are doing well. The market.
    [Show full text]